Franziska Zabel

Franziska Zabel is a prominent inventor based in Lucerne, Switzerland. She has made significant contributions to the field of allergy research, particularly in developing compositions aimed at reducing cat allergenicity. Her innovative work has led to the filing of multiple patents, showcasing her dedication to improving the lives of those affected by allergies.

Latest Patents

Franziska Zabel holds 2 patents related to her research on cat allergies. Her latest patents focus on compositions that utilize virus-like particles (VLP) and Fel d1 proteins to induce efficient immune responses in cats. These compositions are designed to reduce the allergenicity of cats, providing a potential solution for humans exposed to these allergens. The inventions aim to treat and prevent cat allergies effectively.

Career Highlights

Zabel is affiliated with the University of Zurich, where she conducts her research and develops her innovative solutions. Her work has garnered attention in the scientific community, and she continues to explore new avenues in allergy treatment.

Collaborations

Franziska Zabel collaborates with esteemed colleagues, including Martin Bachmann and Gary Jennings. Their combined expertise enhances the research and development of effective allergy treatments.

Conclusion

Franziska Zabel's contributions to allergy research, particularly in developing compositions against cat allergies, highlight her role as an innovative inventor. Her work promises to make a significant impact on the lives of allergy sufferers.

Profile summary based on public USPTO records.